COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1618: Articles 16171-16180  | Next

Drug repurposing to face Covid-19: Celastrol, a potential leading drug capable of inhibiting SARS-CoV-2 replication and induced inflammation
Fuzo, C. A., Martins, R. B., Fraga-Silva, T. F. C., Amstalden, M. K., Canassa-DeLeo, T., Souza, J. P., Lima, T. M., Faccioli, L. H., Franca, S. C., Bonato, V. L. D., Neto, E. A., Dias-Baruffi, M.
10.1101/2021.04.20.439992 — Posted: 2021-04-20
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Li, T., Han, X., Gu, C., Guo, H., Zhang, H., Wang, Y., Hu, C., Wang, K., Liu, F., Luo, F., Zhang, Y., Hu, J., wang, W., Li, S., Hao, Y., Shen, M., Huang, J., Long, Y., Song, S., Wu, R., Mu, S., Chen, Q., Gao, F., Wang, J., Long, S., Li, L., Wu, Y., Gao, Y., Xu, W., Cai, X., Qu, D., Zhang, Z., Zhang, H., Li, N., Gao, Q., Zhang, g., He, C., Wang, W., Ji, X., Tang, N., Yuan, Z., Xie, Y., Zhang, B., Yang, H., Huang, A., Jin, A.
10.1101/2021.04.19.440481 — Posted: 2021-04-20
Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
Krause, E., Puyskens, A., Bourquain, D., Brinkmann, A., Biere, B., Schaade, L., MIchel, J., Nitsche, A.
10.1101/2021.04.18.21255688 — Posted: 2021-04-20
A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes
Moni, M., Madathil, T., Sathyapalan, D., Menon, V., Gutjahr, G., Edathadathil, F., Sureshkumar, D., Prasanna, P., Jose, S., Jerome, R., Krishnan, A., Pillai, I., Kumar, G., Nair, B., Jayant, A.
10.1101/2021.04.15.21255300 — Posted: 2021-04-20
Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization
Rossignol, J.-F., Bardin, M. C., Oaks, J. B., Bostick, B. G., Vora, K. N., Fulgencio, J., Mogelnicki, D., Brechot, C.
10.1101/2021.04.19.21255441 — Posted: 2021-04-20
INTRANASAL APPLICATION OF LACTOCOCCUS LACTIS W 136 BACTERIA EARLY IN COVID 19 INFECTION MAY HAVE A BENEFICIAL IMMUNOMODULATORY EFFECT: A PROOF-OF-CONCEPT STUDY
Mfuna Endam, L., Tremblay, C., Filali, A., Desrosiers, M. Y.
10.1101/2021.04.18.21255699 — Posted: 2021-04-20
Post-COVID-19 syndrome in outpatients: a cohort study
Desgranges, F., Tadini, E., Munting, A., Regina, J., Paraskevas, F., Karachalias, E., Viala, B., Suttels, V., Haefliger, D., Kampouri, E., Van Singer, M., Tschopp, J., Rochat Stettler, L., Schaad, S., Brahier, T., Hugli, O., Mueller Chabloz, Y., Gouveia, A., Opota, O., Carron, P.-N., Guery, B., Papadimitriou-Olivgeris, M., Boillat-Blanco, N.
10.1101/2021.04.19.21255742 — Posted: 2021-04-20
A Simplified Point-of-Care Lung Ultrasound Protocol to Detect Coronavirus Disease 2019 in Inpatients: A Prospective Observational Study
Heyne, T. F., Geisler, B. P., Negishi, K., Choi, D. S., Al Saud, A. A., Marinacci, L. X., Smithedajkul, P. Y., Devaraj, L. R., Little, B. P., Mendoza, D. P., Flores, E. J., Petranovic, M., Toal, S. P., Shokoohi, H., Liteplo, A. S.
10.1101/2021.04.19.21254974 — Posted: 2021-04-20
Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
Holden, T. M., Richardson, R. A., Arevalo, P., Duffus, W. A., Runge, M., Whitney, E., Wise, L., Ezike, N. O., Patrick, S., Cobey, S., Gerardin, J.
10.1101/2021.04.14.21255476 — Posted: 2021-04-20
Assessing the Mortality Impact of the COVID-19 Pandemic in Florida State Prisons
Marquez, N., Littman, A., Rossi, V., Everett, M., Tyagi, E., Johnson, H., Dolovich, S.
10.1101/2021.04.14.21255512 — Posted: 2021-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).